Jounce Therapeutics

Juno Therapeutics

This biopharmaceutical company develops immunotherapies using genetically engineered cells to treat patients with various types of cancer.

Xilio Therapeutics

This biotechnology company develops tumour-activated immuno-oncology therapies designed to treat patients with solid cancers while reducing systemic side effects.

ALX Oncology

This clinical-stage biopharmaceutical company develops novel therapies to treat cancer patients by expanding the possibilities of immuno-oncology and antibody-drug conjugates.

Arcus Biosciences

This biopharmaceutical company develops molecules and combination therapies for patients with various forms of cancer and immune diseases.

Harpoon Therapeutics (NASDAQ: HARP)

This clinical-stage immunotherapy company develops T-cell engager therapies to treat patients suffering from cancer and other diseases.

Tizona Therapeutics

This biopharmaceutical company develops first-in-class cancer immunotherapies and antibody-based treatments for patients with advanced solid tumours.

Black Diamond Therapeutics

This clinical-stage company develops precision oncology medicines and small molecule therapies for patients with genetically defined cancers.

Bicara Therapeutics

This biotechnology company develops dual-action biologics to treat patients with solid tumours by targeting the tumour microenvironment.